查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844201

尿道結石管理設備市場（按設備類型、治療類型、設備材料、應用和最終用戶分類）—2025-2032 年全球預測

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，尿道結石管理設備市場將成長 9.037 億美元，複合年成長率為 7.93%。

主要市場統計數據
基準年2024年 4.9076億美元
預計2025年 5.2703億美元
預測年份：2032年 9.037億美元
複合年成長率（%） 7.93%

全面介紹當前臨床實踐、技術創新和相關人員的壓力，這些因素影響尿道結石治療設備的開發和採用

尿路結石管理設備正處於技術創新、臨床通訊協定發展和醫療服務模式變革的動態交會點。過去十年，診斷影像、內視鏡視覺化和腔內能量傳輸技術的不斷進步，共同拓展了治療方案，並最佳化了病患照護路徑。本簡介概述了當前的發展態勢，重點介紹瞭如何客製化設備設計、材料科學和操作人體工學，以最大限度地降低侵入性，同時最佳化結石去除和患者康復。

如今，臨床醫生優先考慮能夠提供可重複結果且安全性可預測的設備，而製造商則透過專注於模組化、一次性使用選項以及與數位平台整合以提供操作指導來應對這一挑戰。付款人和醫療系統要求在吞吐量和術後資源利用率方面取得顯著提升，這正在塑造採購偏好。總體而言，該產業的特點是技術快速迭代、更注重用戶體驗，以及不斷調整價值提案以滿足臨床和經濟績效要求。

設備小型化、一次性技術和整合數位平台的轉型正在再形成程式路徑和採用

尿道結石治療領域正在經歷變革時期，這得益於設備小型化、能量輸送方式以及數位診斷整合技術的進步。微型輸尿管鏡和軟式內視鏡正在擴大內視鏡治療結石的範圍，並減少對侵入性更強的手術的依賴。同時，腔內碎石技術的改進，尤其是在平衡碎石效率和熱安全性的雷射平台方面的改進，正在改變手術流程，並增加可在門診完成的病例數量。

除了單純的設備性能之外，為了解決感染控制問題並簡化滅菌工作流程，一次性和一次性使用技術也呈現明顯的趨勢。提供程式分析和影像增強工具的數據驅動型設備的興起，為結果追蹤和操作員培訓創造了機會。此外，監管預期和報銷框架也在同步發展，要求製造商不僅要證明臨床有效性，還要證明可衡量的營運效益。

分析到 2025 年不斷變化的關稅制度和貿易重組將如何影響整個醫療設備供應鏈的籌資策略、成本結構和採購彈性。

2025年關稅政策和國際貿易動態的變化，為製造商、供應商和醫療保健採購負責人帶來了新的營運考量。某些醫療設備零件的關稅上調，加上地緣政治發展引發的供應鏈重組，迫使相關人員重新評估籌資策略和成本結構。重要的是，這些貿易措施凸顯了建立一個靈活的採購框架的必要性，該框架應能有效應對跨境成本和前置作業時間的波動。

為了應對這種情況，許多公司正在多元化其供應商基礎，並評估近岸外包機會，以降低其受進口相關波動影響的風險。醫療設備設計人員也在重新審視其物料清單選擇，傾向於選擇貿易壁壘較低的本地可用材料和子組件。臨床護理提供者的採購團隊擴大納入總擁有成本分析，其中考慮了關稅影響、物流和庫存緩衝，這些因素會影響採購週期以及與製造商和經銷商的合約安排。

深度細分洞察，將產品類型、治療方式、材料、臨床應用和最終用戶需求與策略性產品定位連結起來

有效的細分分析能夠揭示臨床需求、技術適用性和購買行為之間的交集。依設備類型，本研究涵蓋導管導引線、碎石機、支架和輸尿管鏡。導管導引線著重於尖端控制和塗層技術，碎石機追求高效節能的碎石效果，同時最大限度地減少對側支組織的影響，支架則透過材料科學最佳化患者舒適度和植入性，而輸尿管鏡則在光學性能與靈活性和耐用性之間取得平衡。依治療類型，本研究涵蓋體外震波碎石術、體內碎石術和經皮腎鏡碎石術市場，每種治療方式都對能量輸送、接取設備和影像整合有著獨特的設備需求。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 人工智慧演算法的整合度不斷提高，以實現腎結石的自動檢測和治療計劃
  • 一次性輸尿管鏡需求激增，以降低交叉污染的風險
  • 超音波和雷射碎石技術的進步使得結石破碎速度更快
  • 擴大遠端醫療和遠端患者監護用於術後尿道結石護理
  • 開發生物可吸收支架，最大程度減少患者不適並減少二次手術
  • 增加對可攜式超音波導引碎石設備的投資，用於照護現場
  • 透過 3D 列印的患者特定腎臟模型更重視個人化治療途徑

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章尿道結石管理設備市場（依設備類型）

  • 導管導引線
  • 碎石機
  • 支架
  • 輸尿管鏡

第9章尿道結石管理設備市場（依治療類型）

  • 體外震波碎石術
  • 體內碎石術
  • 經皮腎鏡取石術

第 10 章尿道結石管理設備市場（依設備材料）

  • 金屬基元件
  • 基於聚合物的設備

第 11 章尿道結石管理設備市場（依應用）

  • 膀胱結石
  • 腎結石
  • 輸尿管結石

第 12 章尿道結石管理設備市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 專科診所

第13章尿道結石管理設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章尿道結石管理設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。尿道結石管理設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Advanced MedTech Holdings
    • AKSM, Ltd.
    • Avvio Medical, Inc.
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Calyxo Inc.
    • Coloplast A/S
    • Cook Group Incorporated
    • DirexGroup
    • Dornier MedTech GmbH
    • Dyne Medical Group Inc.
    • EMS Electro Medical Systems SA
    • EDAP TMS SA
    • Elmed Lithotripsy Systems
    • EndoTheia, Inc.
    • Karl Storz GmbH & Co. KG
    • Nissha Medical Technologies
    • Olympus Corporation
    • Quanta System SpA
    • Richard Wolf GmbH
    • Siemens Healthineers
    • SonoMotion
    • Teleflex Incorporated
Product Code: MRR-ED54C46E9009

The Urolithiasis Management Devices Market is projected to grow by USD 903.70 million at a CAGR of 7.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 490.76 million
Estimated Year [2025] USD 527.03 million
Forecast Year [2032] USD 903.70 million
CAGR (%) 7.93%

A comprehensive introduction that frames current clinical practices, technological innovation, and stakeholder pressures shaping urolithiasis device development and adoption

Urolithiasis management devices occupy a dynamic intersection of engineering innovation, evolving clinical protocols, and shifting care delivery models. Over the past decade, incremental improvements in imaging, endoscopic visualization, and intracorporeal energy delivery have converged to expand treatment options and refine patient pathways. This introduction synthesizes the current landscape by highlighting how device design, material science, and procedural ergonomics are increasingly tailored to minimize invasiveness while optimizing stone clearance and patient recovery.

Clinicians now prioritize devices that offer reproducible outcomes with predictable safety profiles, and manufacturers respond by focusing on modularity, single-use options, and integration with digital platforms for procedural guidance. Payers and health systems demand demonstrable improvements in throughput and post-procedure resource utilization, which in turn shapes procurement preferences. In sum, the sector is characterized by rapid technical iteration, growing emphasis on user experience, and a continuous recalibration of value propositions to meet clinical and economic performance requirements.

Illustration of transformative shifts driven by device miniaturization, disposable technologies, and integrated digital platforms reshaping procedural pathways and adoption

The landscape of urolithiasis management is undergoing transformative shifts driven by advances in device miniaturization, energy delivery modalities, and integration of digital diagnostics. Miniaturized ureteroscopes and flexible endoscopes are widening the spectrum of stones that can be managed endoscopically, reducing reliance on more invasive procedures. Concurrently, enhancements in intracorporeal lithotripsy-particularly the refinement of laser platforms that balance fragmentation efficiency with thermal safety-have altered procedural algorithms, increasing case volumes that can be completed in ambulatory settings.

Beyond pure device performance, there is a pronounced movement toward disposability and single-use technologies to address infection control concerns and streamline sterilization workflows. The rise of data-enabled devices that provide procedural analytics and imaging enhancement tools is creating opportunities for outcome tracking and operator training. Moreover, regulatory expectations and reimbursement frameworks are evolving in tandem, encouraging manufacturers to demonstrate not only clinical efficacy but also measurable operational benefits, which reshapes product positioning and commercialization strategies.

Analysis of how evolving tariff regimes and trade realignments in 2025 are influencing sourcing strategies, cost structures, and procurement resilience across the device supply chain

Tariff policy changes and international trade dynamics in 2025 have introduced new operational considerations for manufacturers, suppliers, and healthcare purchasers. Increased duties on specific medical device components, coupled with supply chain realignments catalyzed by geopolitical developments, have compelled stakeholders to reassess sourcing strategies and cost structures. Importantly, these trade measures have emphasized the need for resilient procurement frameworks that account for variable cross-border costs and lead times.

In response, many organizations are diversifying supplier bases and evaluating nearshoring opportunities to mitigate exposure to import-related volatility. Device designers are also reconsidering bill-of-materials choices, favoring materials and subcomponents that are locally available or subject to lower trade barriers. For clinical providers, procurement teams are increasingly incorporating total-cost-of-ownership analyses that account for tariff impacts, logistics, and inventory buffers, thereby influencing purchasing cycles and contractual arrangements with manufacturers and distributors.

Deep segmentation insights that connect device types, treatment modalities, materials, clinical applications, and end-user requirements to strategic product positioning

Effective segmentation analysis illuminates where clinical need, technology fit, and purchasing behavior intersect. Based on Device Type, the landscape is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes, revealing distinct development trajectories: guidewires emphasize tip control and coating technology, lithotripters pursue energy-efficient fragmentation with minimal collateral tissue effect, stents optimize patient comfort and encrustation resistance through material science, and ureteroscopes balance optics with flexibility and durability. Based on Treatment Type, the market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy, and each modality drives unique device requirements related to energy delivery, access instrumentation, and imaging integration.

Based on Device Material, the market is studied across Metal-Based Devices and Polymer-Based Devices, which underlines trade-offs between strength, flexibility, cost, and biocompatibility that influence clinical selection and lifecycle management. Based on Application, the market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones, highlighting how stone location dictates access strategy, instrument size, and post-procedural follow-up. Finally, based on End User, the market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, with each setting prioritizing different value drivers such as throughput, device turnaround time, or procedural complexity. Taken together, these segmentation lenses provide a multi-dimensional view that informs product development priorities and commercialization tactics.

Key regional considerations outlining how divergent regulatory, reimbursement, and clinical practice environments across major geographies shape device adoption and commercialization

Regional dynamics influence clinical practice patterns, regulatory pathways, and reimbursement landscapes, which in turn shape device design and go-to-market strategies. In the Americas, health systems exhibit a high adoption rate of minimally invasive techniques and place strong emphasis on evidence demonstrating operational efficiency and patient-centered outcomes, prompting vendors to support health economic narratives alongside clinical data. Procurement cycles in this region are often influenced by integrated delivery networks and group purchasing organizations, which amplifies the importance of scalable supply models and service support.

In Europe, Middle East & Africa, heterogeneity in regulatory expectations and payer structures requires adaptable market entry strategies that balance localized clinical validation with flexible commercial models. Stakeholders in this region may prioritize cost-effectiveness and durability, especially in systems with constrained capital allocation. Within the Asia-Pacific region, rapid infrastructure development and high procedure volumes create significant demand for cost-effective, scalable devices and single-use solutions that address infection control and throughput. Across all regions, partnerships with local distributors and targeted clinician engagement remain central to adoption and long-term market development.

Critical competitive insights into how established players and agile innovators are differentiating through product design, service models, and strategic partnerships

The competitive landscape comprises established device manufacturers, innovative medtech startups, and specialized component suppliers, each pursuing differentiated strategies to capture clinical preference and procurement attention. Leading product development teams focus on aligning design features with clinician workflows, emphasizing ergonomics, intuitive controls, and interoperability with imaging systems. Contracting and post-market support capabilities increasingly differentiate suppliers, as hospitals and surgical centers seek partners that provide training, maintenance, and data analytics to optimize utilization.

Concurrently, some companies are adopting focused plays-such as single-use platforms or high-powered laser systems-while others concentrate on incremental improvements to guidewires and stents through advanced materials. Strategic alliances, licensing arrangements, and targeted acquisitions are common tactics used to accelerate capability expansion, particularly in areas like imaging integration and disposable instrument portfolios. Ultimately, companies that combine clinical credibility, supply resilience, and compelling value demonstrations are positioned to lead in a landscape that prizes both innovation and operational performance.

Actionable recommendations that align product design, manufacturing agility, supply chain resilience, and evidence generation to accelerate clinical adoption and commercial success

Industry leaders should adopt a multi-pronged approach that aligns R&D priorities with real-world clinical workflows and procurement demands. First, prioritize human-centered design to reduce procedure time and improve user ergonomics, ensuring that new devices integrate seamlessly with existing imaging and navigation systems. Second, invest in modular and scalable manufacturing strategies that allow rapid shifts between reusable and single-use production pathways, thereby responding to infection control concerns and procurement preferences.

Third, strengthen supply chain resilience by diversifying suppliers, evaluating nearshoring opportunities, and embedding tariff and logistics scenarios into commercial planning. Fourth, cultivate robust clinical evidence and health economic dossiers that speak directly to institutional decision-makers, demonstrating not only clinical outcomes but also downstream operational benefits. Lastly, pursue targeted partnerships with regional distributors and training centers to accelerate adoption, while offering post-sale analytics and education services that support sustained utilization and long-term customer relationships.

A transparent mixed-methods research methodology integrating clinician interviews, technical literature review, and scenario analysis to validate trends and implications

This research synthesis is built on a mixed-methods approach that triangulates primary qualitative engagement with secondary public domain sources and technical literature. Primary inputs included structured interviews with clinicians across key specialties, procurement leads from diverse care settings, and industry executives to validate technology trends and identify operational pain points. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, device technical specifications, and publicly available guidance from professional societies to ensure technical accuracy and context.

Analytical methods combined thematic coding of qualitative interviews with cross-sectional comparison of device features and clinical application requirements. Where applicable, supply chain and policy impacts were assessed through scenario analysis to understand sensitivity to trade and logistics variables. Throughout, findings were corroborated across multiple sources to strengthen validity and presented with transparency about data provenance and methodological limits so that decision-makers can interpret insights with appropriate confidence.

Concluding synthesis highlighting the convergence of clinical innovation, operational realities, and strategic imperatives that will define future progress in urolithiasis device management

The management of urolithiasis is at an inflection point where iterative device innovation, procedural evolution, and supply chain complexities converge to redefine clinical pathways. Advances in scope flexibility, energy delivery, and single-use technologies are expanding minimally invasive options and supporting shifts toward ambulatory care. Meanwhile, trade dynamics and regional heterogeneity necessitate more sophisticated procurement strategies and localized commercialization approaches. Decision-makers must therefore balance the promise of technological improvements with pragmatic considerations around supply resilience and evidence-backed value.

Moving forward, stakeholders who successfully align product development with clinician workflows, invest in demonstrable outcome metrics, and build flexible manufacturing and distribution models will capture the greatest opportunity to influence care delivery. The convergence of clinical needs, regulatory expectations, and operational priorities creates fertile ground for innovations that are not only clinically superior but also operationally compelling, ultimately improving patient outcomes and health system efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing integration of artificial intelligence algorithms for automated kidney stone detection and treatment planning
  • 5.2. Surge in demand for single-use disposable ureteroscopes to reduce cross-contamination risks
  • 5.3. Advancements in ultrasonic and laser lithotripsy technologies for faster stone fragmentation
  • 5.4. Expansion of telemedicine and remote patient monitoring for post-operative urolithiasis care
  • 5.5. Development of bioresorbable stents to minimize patient discomfort and reduce secondary procedures
  • 5.6. Rising investments in portable ultrasound-guided lithotripsy devices for point-of-care applications
  • 5.7. Increasing focus on personalized treatment pathways through 3D-printed patient-specific kidney models

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urolithiasis Management Devices Market, by Device Type

  • 8.1. Guidewires
  • 8.2. Lithotripters
  • 8.3. Stents
  • 8.4. Ureteroscopes

9. Urolithiasis Management Devices Market, by Treatment Type

  • 9.1. Extracorporeal Shock Wave Lithotripsy
  • 9.2. Intracorporeal Lithotripsy
  • 9.3. Percutaneous Nephrolithotomy

10. Urolithiasis Management Devices Market, by Device Material

  • 10.1. Metal-Based Devices
  • 10.2. Polymer-Based Devices

11. Urolithiasis Management Devices Market, by Application

  • 11.1. Bladder Stones
  • 11.2. Kidney Stones
  • 11.3. Ureteral Stones

12. Urolithiasis Management Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Urolithiasis Management Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urolithiasis Management Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urolithiasis Management Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Advanced MedTech Holdings
    • 16.3.2. AKSM, Ltd.
    • 16.3.3. Avvio Medical, Inc.
    • 16.3.4. Becton, Dickinson and Company
    • 16.3.5. Boston Scientific Corporation
    • 16.3.6. Calyxo Inc.
    • 16.3.7. Coloplast A/S
    • 16.3.8. Cook Group Incorporated
    • 16.3.9. DirexGroup
    • 16.3.10. Dornier MedTech GmbH
    • 16.3.11. Dyne Medical Group Inc.
    • 16.3.12. E.M.S. Electro Medical Systems S.A.
    • 16.3.13. EDAP TMS SA
    • 16.3.14. Elmed Lithotripsy Systems
    • 16.3.15. EndoTheia, Inc.
    • 16.3.16. Karl Storz GmbH & Co. KG
    • 16.3.17. Nissha Medical Technologies
    • 16.3.18. Olympus Corporation
    • 16.3.19. Quanta System S.p.A.
    • 16.3.20. Richard Wolf GmbH
    • 16.3.21. Siemens Healthineers
    • 16.3.22. SonoMotion
    • 16.3.23. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 224. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 225. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. GCC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 260. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 261. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. G7 UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. NATO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARK